Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8848271rdf:typepubmed:Citationlld:pubmed
pubmed-article:8848271lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C0003595lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C0205422lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C0022341lld:lifeskim
pubmed-article:8848271lifeskim:mentionsumls-concept:C1709269lld:lifeskim
pubmed-article:8848271pubmed:issue1lld:pubmed
pubmed-article:8848271pubmed:dateCreated1996-10-21lld:pubmed
pubmed-article:8848271pubmed:abstractTextApolipoprotein E (ApoE) phenotypes and corresponding allele frequencies were examined in 72 patients (50-90 years of age) with sporadic Alzheimer's disease (AD) and 83 elderly controls (61-96 years of age) in Hokkaido, the northern part of Japan. The frequency of the ApoE-epsilon 4 allele was significantly higher in the patients with either early-onset (age < 65 years) AD (0.40) or late-onset AD (0.26) than in controls (0.07), while the patients developing AD before 50 years of age had no epsilon 4 allele. The mean age at onset of AD was significantly lower in the ApoE-epsilon 4 homozygotes compared to that in the patients with either one or no epsilon 4 allele (60.2, 71.3 and 70.3 years, respectively). Our results indicate that the ApoE-epsilon 4 allele is associated with susceptibility to Japanese sporadic AD developing after 50 years of age and homozygosity for the epsilon 4 allele shifts the onset to earlier age.lld:pubmed
pubmed-article:8848271pubmed:languageenglld:pubmed
pubmed-article:8848271pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8848271pubmed:citationSubsetIMlld:pubmed
pubmed-article:8848271pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8848271pubmed:statusMEDLINElld:pubmed
pubmed-article:8848271pubmed:monthMarlld:pubmed
pubmed-article:8848271pubmed:issn0304-3940lld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:ChibaSSlld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:SaitoMMlld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:EtoMMlld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:MiyagishiTTlld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:MakinoIIlld:pubmed
pubmed-article:8848271pubmed:authorpubmed-author:NunomuraAAlld:pubmed
pubmed-article:8848271pubmed:issnTypePrintlld:pubmed
pubmed-article:8848271pubmed:day8lld:pubmed
pubmed-article:8848271pubmed:volume206lld:pubmed
pubmed-article:8848271pubmed:ownerNLMlld:pubmed
pubmed-article:8848271pubmed:authorsCompleteYlld:pubmed
pubmed-article:8848271pubmed:pagination17-20lld:pubmed
pubmed-article:8848271pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:meshHeadingpubmed-meshheading:8848271-...lld:pubmed
pubmed-article:8848271pubmed:year1996lld:pubmed
pubmed-article:8848271pubmed:articleTitleApolipoprotein E polymorphism and susceptibility to early- and late-onset sporadic Alzheimer's disease in Hokkaido, the northern part of Japan.lld:pubmed
pubmed-article:8848271pubmed:affiliationDepartment of Psychiatry and Neurology, Asahikawa Medical College, Japan. nuno@asahikawa-med.ac.jplld:pubmed
pubmed-article:8848271pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8848271pubmed:publicationTypeClinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8848271lld:pubmed